Meiji Yasuda Asset Management Co Ltd.
Position in GILD — Gilead Sciences, Inc.
CIK 1491685
Tokyo, M0
Position in GILD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,221,903
+$2,480,754 QoQ
Shares Held
33,417
+167.5% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#619
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Meiji Yasuda Asset Management Co Ltd. holds $92,414,200 across 8 Drug Manufacturers - General names. GILD ranks #7 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
99,291 | $25,216,935 | |
| 2 | ABBV |
AbbVie Inc.
|
94,867 | $23,872,331 | |
| 3 | LLY |
ELI LILLY & Co
|
14,900 | $17,871,508 | |
| 4 | MRK |
Merck & Co., Inc.
|
61,840 | $7,946,440 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
102,981 | $5,933,765 | |
| 6 | AMGN |
Amgen Inc
|
12,101 | $4,382,014 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
33,417 | $4,221,903 | |
| 8 | PFE |
Pfizer Inc
|
123,310 | $2,969,304 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,221,903 | 33,417 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,741,149 | 12,493 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,517,557 | 12,364 | Shares | Defined | 2026-02-06 | |
| 2025-09-30 | $1,114,440 | 10,040 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,049,384 | 9,465 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,836,545 | 25,315 | Shares | Defined | 2025-05-16 | |
| 2024-12-31 | $2,379,728 | 25,763 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,045,109 | 24,393 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,675,936 | 24,427 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $3,592,912 | 49,050 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $6,363,335 | 78,550 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $6,183,074 | 82,507 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,742,210 | 48,556 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $4,052,171 | 48,839 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $6,919,939 | 80,605 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,561,661 | 90,155 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $5,676,321 | 91,835 | Shares | Defined | 2022-08-16 | |
| 2022-03-31 | $6,610,840 | 111,200 | Shares | Defined | 2022-05-17 | |
| 2021-12-31 | $8,461,098 | 116,528 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,515,119 | 93,273 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $6,420,162 | 93,235 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $7,547,362 | 116,778 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $5,527,067 | 94,869 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $4,780,260 | 75,649 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $6,526,743 | 84,829 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $2,702,125 | 36,144 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||